An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland

Journal of Hospital Infection

Volumn 33, Issue 4, 1996, Pages 249-262

  Hobson, R P ^a   MacKenzie, F M ^a   Gould, I M ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

ESBL; Klebsiella pneumoniae; Outbreak

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; BETA LACTAMASE; CARBAPENEM DERIVATIVE;

ABDOMINAL ABSCESS; ANTIBIOTIC RESISTANCE; ARTICLE; ASSISTED VENTILATION; BACTERIUM CONTAMINATION; CASE FINDING; ENZYME ACTIVITY; GERIATRIC HOSPITAL; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MENINGITIS; PATIENT TRANSPORT; PNEUMONIA; POSTOPERATIVE COMPLICATION; RESPIRATORY SYSTEM; SCREENING; SEPTICEMIA; SURGICAL WARD; UNITED KINGDOM; URINARY TRACT INFECTION; WOUND INFECTION;

EID: 0029794672     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(96)90011-0     Document Type: Article

References (38)

1. Payne DJ, Marriot MS, Amyes SJB. Characterisation of a unique ceftazidime-hydrolysing β-lactamase, TEM-E2. J Med Microbiol 1990; 32: 131-134.
2. Jacoby GA, Madeiros AA. More extended spectrum β-lactamases. Minireview. Antimicrob Agents Chemother 1991; 35: 1697-1704.
3. Price DJE, Sleigh JD. Control of infection due to Klebsiella aerogenes in neuro-surgical unit by withdrawal of all antibiotics. Lancet 1970; ii: 1213-1215.
4. Bure A, Legrand P, Arlet G, Jarler V, Paul G. Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam. Eur J Clin Micro Infect Dis 1988; 7: 780-782.
5. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ. Nosocomial outbreak of Klebsiella infection resistant to late generation cephalosporins. Ann Intern Med 1993; 119: 353-358.
6. Johnson AP, Weinbren MJ, Ayling-Smith B, Du Bois SK, Amyes SGB, George RC. Outbreak of infection in two UK hospitals caused by a strain of Klebsiella pneumoniae resistant to cefotaxime and ceftazidime. J Hosp Infect 1992; 20: 97-103.
7. Taylor ME, Oppenheim BA. Selective decontamination of the gastrointestinal tract as an infection control measure. J Hosp Infect 1991; 17: 271-278.
8. French GL, Shannon KP, Simmons N. Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and β-lactam-β-lactamase inhibitor combinations by hyperproduction of SHV-5 β-lactamase. J Clin Micro 1966; 34: 358-363.
9. Bauernfeind A, Rosenthal E, Eberlein E, Holley M, Schweighart S. (1993). Spread of Klebsiella pneumoniae producing SHV-5 beta-lactamase among hospitalized patients. Infection 1993; 21: 88-22.
10. Sirot DL, Goldstein FW, Soussy CJ et al. Resistance to cefotaxime and seven other β-lactams in members of the family enterobacteriaceae: a 3 year survey in France. Antimicrob Agents Chemother 1992; 36: 1677-1681.
11. Arlet G, Rouveau M, Casin I, Bouvet PJM, Lagrange PH, Philippon A. Molecular Epidemiology of Klebsiella pneumoniae strains that produce SHV-4 β-lactamase and which were isolated in 14 French hospitals. J Clin Micro 1994; 32: 2553-2558.
12. Bradford PA, Cherubin CE, Idemyor V, Rasmussen BA, Bush K. Multiply-resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing β-lactamases in a single isolate. Antimicrob Agents Chemother 1994; 38: 761-766.
13. British Society for Antimicrobial Chemotherapy working party. A guide to sensitivity testing, J Antimicrob Chemother 1991; 27 (Supplement D): 22-45.
14. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad spectrum β-lactamases conferring transferrable resistance to newer β-lactam agents in enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10: 867-868.
15. Palfreyman JM. Klebsiella serotyping by countercurrent immunoelectrophoresis. J Hyg 1978; 81: 219-225.
16. Kaufmann P, Pitt T. Pulsed-field gel electrophoresis of bacterial DNA. In: Chart H, Ed. Methods in Practical Laboratory Bacteriology 1st edn. London: Times Mirror International 1994; 83-92.
17. Matthew M, Harris AM, Marshall MJ, Ross GW. The use of isoelectric focusing for detection and identification of β-lactamases. J General Microbiol 1975; 88: 169-178.
18. O'Callaghan CH, Kirby SM. (1978). Methods of antibiotic assay. Cephalosporins. In: Reeves DS, Phillips I, Williams JD, Wise R, Eds. Laboratory Methods in Antimicrobial Chemotherapy, 1st edn. London: Churchill Livingstone 1978; 181-191.
19. British National Formulary, number 29, London: The British Medical Association and the Royal Pharmaceutical Society of Great Britain, March 1995.
20. Casewell MW, Phillips I. Hands as a route of transmission for Klebsiella species. BMJ 1977; 2: 1315-1317.
21. Dornbusch K, Miller GH, Hare RS, Shaw KJ. Resistance to aminoglycoside antibiotics in Gram-negative bacilli and staphylococci isolated from blood. Report from a European collaborative study. J Antimicrob Chemother 1990; 26: 131-144.
22. Gould IM, Mackenzie FM, Thomson C. Multi-resistant Klebsiella in Grampian. Lancet 1995; 345: 122.
23. Kliebe C, Nies BA, Meyer JF, Tolxdorff-Neutzling RM, Wiedemann B. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother 1985; 28: 302-307.
24. Arlet G, Rouveau M, Bengoufa D, Nicolas MH, Philippon A. Novel transferable extended-spectrum β-lactamase (SHV-6) from Klebsiella pneumoniae conferring selective resistance to ceftazidime. FEMS Microbiol Lett 1991; 81: 57-62.
25. Bradford PA, Urban C, Jaiswal A et al. SHV-7, a novel cefotaxime-hydrolysing β-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients. Antimicrob Agents Chemother 1995; 39: 899-905.
26. Wiedemann B, Husing W. The use of bacteria producing the aminoglycoside inactivating enzyme ANT-(2″) in an in-vitro model, J Antimicrob Chemother 1985; 15: 251-256.
27. Brun-Buisson C, Legrand P, Rauss A et al. Intestinal decontamination for control of nosocomial multiresistant Gram-negative bacilli. Ann Intern Med 1989; 110: 873-881.
28. Coovadia YM, Johnson AP, Bhana RH, Hutchinson GR, George RC, Hafferjee IE. Multi-resistant Klebsiella pneumoniae in a neonatal nursery: the importance of maintainance of infection control policies and procedures in the prevention of outbreaks. J Hosp Infect 1992; 22: 197-205.
29. Go ES, Urban C, Burns J et al. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymixin B and sulbactam. Lancet 1994; 344: 1329-1332.
30. Weinstein RA, Kabins SA. Strategies for prevention and control of multiple drug-resistant nosocomial infection. Am J Med 1981; 70: 449-454.
31. Rice LB, Willey SH, Papanicolaou GA et al. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic care facility. Antimicrob Agents Chemother 1990; 34: 2193-2199.
32. Cox RA, Mallaghan C, Conquest C, King J. Epidemic methicillin-resistant Staphylococcus aureus: controlling the spread outside hospital. J Hosp Infect 1995; 29: 107-119.
33. Barnass S, O'Mahony M, Sockett PN, Garner J, Franklin J, Tabaqchali S. The tangible cost implications of a hospital outbreak of multiply-resistant salmonella. Epidemiol Infect 1989; 103: 227-234.
34. Yule BF, MacLeod AF, Sharp JCM, Forbes GI. Costing of a hospital-based outbreak of poultry-borne salmonellosis. Epidemiol Infect 1988; 100: 35-42.
35. Mehtar S, Drabu YJ, Mayet F. Expenses incurred during a 5-week epidemic methicillin-resistant Staphylococcus aureus epidemic. J Hosp Infect 1989; 13: 199-200.
36. Kim JH, Gallis HA. Observations on spiraling empiricism: its causes, allure and perils with particular reference to antibiotic therapy. Am J Med 1989; 87: 201-206.
37. Selden R, Lee S, Lan Lou Wang W, Bennett JV, Eickhoff TC. Nosocomial Klebsiella infections: intestinal colonization as a reservoir. Ann Inter Med 1971; 74: 657-664.
38. MacDonald AA, Maple PAC, Kibbler CC et al. Ceftazidime-resistant Klebsiella pneumoniae. Lancet 1991; 337: 1609-1610.